AZD-6482

N/A

Report date: 2025/05/28 16:57:07
NME

Base Information

Drug NameAZD-6482
Drug Alias NameKIN-193AZD-6482TBO-309
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase beta inhibitorsPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase betaPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsIschemic StrokeThrombosisStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesThromBio Holdings Pty LtdHeart Research Institute LtdThe Florey Institute Of Neuroscience And Mental Health
Inactive CompaniesAstrazeneca Pharmaceutical Co Ltd
Active IndicationsIschemic StrokeStroke
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A